# Effect of Darbepoetin in Contrast-induced Nephropathy

> **NCT01197235** · PHASE2,PHASE3 · TERMINATED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 80 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** darbepoetin-α
- **DRUG:** isotonic saline

## Key facts

- **NCT ID:** NCT01197235
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** difficult to enroll targeted participants
- **Last updated:** 2014-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197235, "Effect of Darbepoetin in Contrast-induced Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01197235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
